131 results
Page 5 of 7
424B3
ficxm1s3zlu hz
7 Jun 21
Prospectus supplement
9:16am
424B3
anvx2m4vd1v9l1
7 Jun 21
Prospectus supplement
9:16am
6-K
EX-99.1
7f5mxk vloqjaiq3p2
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
w7s72 up3
3 Jun 21
Prospectus supplement
6:06am
424B3
y1ntm7
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
r7gj3zn41j512t69m
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
wy45iy
2 Jun 21
Prospectus supplement
10:10am
424B3
y2t925sjtmwb
2 Jun 21
Prospectus supplement
10:09am
424B3
upco5253
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
y94cyx
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
cm26k
5 May 21
Business combination disclosure
5:26pm
425
u6vz2azx bp
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
2aim4p7qs bt35vu1hn
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
4ij5h j27
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
6hj5e74n
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
6vi7ex8
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.2
c0bf9v8f1nejea
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
qwmnyb9tmd y3qnts
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.6
zmgigg45fr
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
wb5jwe 7nz
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am